Crossmark

Assessing the acceptability and feasibility of reactive drug administration for malaria elimination in a Plasmodium vivax predominant setting: a qualitative study in two provinces in Thailand

Crossref DOI link: https://doi.org/10.1186/s12889-023-15852-z

Published Online: 2023-07-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suwannarong, Kanokwan

Cotter, Chris

Ponlap, Thanomsin

Bubpa, Nisachon

Thammasutti, Kannika

Chaiwan, Jintana

Finn, Timothy P.

Kitchakarn, Suravadee

Mårtensson, Andreas

Baltzell, Kimberly A.

Hsiang, Michelle S.

Lertpiriyasuwat, Cheewanan

Sudathip, Prayuth

Bennett, Adam
Funding

Funding for this research was provided by:

Global Fund to Fight AIDS, Tuberculosis and Malaria (QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41, QSE-M-UNOPS-UCSF-20864-003-41)
License Information

Text and Data Mining valid from 2023-07-13

Version of Record valid from 2023-07-13
More Information

Article History

Received: 11 January 2023

Accepted: 9 May 2023

First Online: 13 July 2023

Declarations

:

: This study was approved by the Committee on Human Research at the University of California San Francisco (19–28060) and the local Ethics Committee for Research in Human Subjects at Tak Provincial Health office (009/63) and Kanchanaburi Provincial health office (Kor Chor 0032.002/2185). Informed consent was obtained from all individuals participating in this study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below